QuidelOrtho Corp (QDEL) is a in vitro & in vivo diagnostic substances company, listed on the Nasdaq. With a market capitalization of $1.5 billion, QuidelOrtho Corp is a small-cap company. The stock currently trades at $22.60, down 0.62% today, with a 52-week range of $19.50–$41.40. The company trades at a forward P/E of 7.6x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-16.69 | $-16.69 | +45.4% | |
| 2024 | $-30.54 | $-30.54 | -20260.0% | |
| 2023 | $-0.15 | $-0.15 | -101.6% | |
| 2022 | $9.56 | $9.66 | — |